Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

2,450.00p
   
  • Change Today:
    -175.00p
  • 52 Week High: 4,420.00
  • 52 Week Low: 2,350.00
  • Currency: UK Pounds
  • Shares Issued: 5.22m
  • Volume: 33,480
  • Market Cap: £128.01m
  • Beta: 0.01

Latest Deals

Traded Action Notifier PriceAmountValue
28-Apr-25 Buy Bruce Hiscock 2,632.00p 31 £815.92
23-Dec-24 Buy Bruce Hiscock 273.00p 61 £166.53
22-Nov-24 Buy Bruce Hiscock 3,822.00p 24 £917.28
30-Oct-24 Buy Bruce Hiscock 3,330.00p 300 £9,990.00

Largest Deals (365 days)

Traded Action Notifier PriceAmountValue
30-Oct-24 Buy Bruce Hiscock 3,330.00p 300 £9,990.00
22-Nov-24 Buy Bruce Hiscock 3,822.00p 24 £917.28
28-Apr-25 Buy Bruce Hiscock 2,632.00p 31 £815.92
23-Dec-24 Buy Bruce Hiscock 273.00p 61 £166.53

Director Shareholdings

Notifier Holding Value*
Peter John Harrison 297,088 £7,278,656
Ian James Nicholson 13,000 £318,500
Bruce Hiscock 1,236 £30,282

Major Shareholders

Notifier** Holding Value*
Rathbones Investment Management Ltd 5,219,656 £127,881,572
Castlefield Fund Partners Limited 985,000 £24,132,500
SANFORD DELAND ASSET MANAGEMENT LTD 885,000 £21,682,500
Gresham House Asset Management Limited 627,782 £15,380,659
SANFORD DELAND ASSET MANAGEMENT LTD 619,500 £15,177,750
Miton Group plc 508,135 £12,449,308
The Diverse Income Trust plc 302,300 £7,406,350
Schroders plc 284,795 £6,977,478
Wasatch Advisors, Inc. 265,000 £6,492,500
Canaccord Genuity Group Inc 259,940 £6,368,530
Adrian Williams 253,372 £6,207,614

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Bioventix Market Data

Currency UK Pounds
Share Price 2,450.00p
Change Today -175.00p
% Change -6.67 %
52 Week High 4,420.00
52 Week Low 2,350.00
Volume 33,480
Shares Issued 5.22m
Market Cap £128.01m
Beta 0.01

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
7.77% above the market average7.77% above the market average7.77% above the market average7.77% above the market average7.77% above the market average
90.70% above the sector average90.70% above the sector average90.70% above the sector average90.70% above the sector average90.70% above the sector average
Price Trend
70.31% below the market average70.31% below the market average70.31% below the market average70.31% below the market average70.31% below the market average
37.78% below the sector average37.78% below the sector average37.78% below the sector average37.78% below the sector average37.78% below the sector average
Income
58.06% above the market average58.06% above the market average58.06% above the market average58.06% above the market average58.06% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Growth
6.38% below the market average6.38% below the market average6.38% below the market average6.38% below the market average6.38% below the market average
60% below the sector average60% below the sector average60% below the sector average60% below the sector average60% below the sector average

Bioventix Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 10-Apr-25 07-Nov-24
Paid 25-Apr-25 21-Nov-24
Amount 70.00p 87.00p

Trades for 05-Aug-2025

Time Volume / Share Price
14:10 13,388 @ 2,420.00p
16:35 50 @ 2,450.00p
16:35 50 @ 2,450.00p
16:27 11 @ 2,514.00p
16:21 3 @ 2,514.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page